Pharma BD Deal Intelligence

Servier SA / Symphogen A/S

2006 · Acquisition/Merger · Complete

Announcement Sentiment

88

Strongly positive

Outcome Score

66

Largely worked — most objectives met.

Servier acquired Symphogen, a leading antibody discovery company.

Key facts

Announced May 16, 2006
Closed Jun 04, 2020
Deal type Acquisition/Merger
Therapeutic area Oncology
Indications Oncology (Antibody Discovery)
Key assets Sym004

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals